Related Experiment Video
Updated: Aug 5, 2026

09:09
In Silico Clinical Trials for Cardiovascular Disease
Published on: May 27, 2022
Next-Generation Cardiovascular Imaging in Precision Medicine: Integrating Functional Imaging, Artificial
Carmine Siniscalchi1, Manuela Basaglia1, Vincenzo Russo2
1Internal Medicine Department, Parma University Hospital, 43125 Parma, Italy.
Diagnostics (Basel, Switzerland)
|July 28, 2026
Summary
Cardiovascular imaging advances offer multidimensional patient assessment beyond anatomy. Integrating imaging with AI and biomarkers enables personalized risk stratification for better cardiovascular disease management.
Area of Science:
- Cardiovascular Medicine
- Medical Imaging Technology
- Artificial Intelligence in Healthcare
Background:
- Cardiovascular and vascular diseases are leading global causes of death.
- Traditional imaging focused on anatomy; modern imaging evaluates function, hemodynamics, and inflammation.
- Technological progress drives a shift toward multidimensional cardiovascular assessment.
Purpose of the Study:
- To review current advances in cardiovascular and vascular imaging.
- To discuss the translational implications of these imaging advancements.
- To highlight future directions for integrating imaging, AI, and precision medicine.
Main Methods:
- Review of recent technological progress in echocardiography, cardiovascular magnetic resonance, computed tomography, nuclear imaging, intravascular imaging, and point-of-care ultrasound.
- Discussion of artificial intelligence, radiomics, and predictive analytics in cardiovascular imaging.
- Integration of imaging findings with biomarkers, clinical scores, and machine learning models.
Main Results:
- Advanced echocardiography improves functional and prognostic assessment in coronary artery disease.
- Cardiac MRI provides unique insights into myocardial fibrosis, perfusion, and hemodynamics.
- CT, hybrid imaging, and intravascular techniques enhance plaque characterization, inflammation assessment, and interventional guidance.
- Point-of-care ultrasound expands access to rapid cardiovascular assessment.
- Integration strategies promise personalized risk stratification for complex cardiovascular conditions.
Conclusions:
- Cardiovascular imaging has evolved to a multidimensional approach, integrating function, hemodynamics, and tissue composition.
- Technological innovations, including AI, are revolutionizing cardiovascular disease diagnosis and risk assessment.
- The future lies in integrating advanced imaging, AI, and precision medicine for personalized patient care.
Related Concept Videos
Imaging Studies for Cardiovascular System V: CT
Cardiac computed tomography (CT) scanning is an advanced cardiac imaging technique that utilizes CT technology, with or without intravenous (IV) contrast, to produce accurate cross-sectional virtual slices of specific areas of the heart, coronary circulation, and major blood vessels such as the aorta, pulmonary veins, and arteries. The computer processes these slices to generate three-dimensional images. Multidetector CT (MDCT) is a rapid form of CT scanning that captures multiple slices...
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...